Cholecystokinin A Receptor Knockdown Diminishes Colon Cancer Cell Invasive Potential via Modulation of Integrin/FAK, EMT, and uPA/uPAR/MMP2 Axis

Oncology Research · Published 2026-01-01 · DOI 10.32604/or.2026.074231

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.32604/or.2026.074231

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• ANLN: A New Hub in Glutamine Metabolism of Lung Adenocarcinoma by scRNA-Seq and Machine Learning · Oncology Research · 2026 · Same journal
• Dual Immune Checkpoint Blockade in Synchronous Hepatocellular and Renal Cell Carcinoma: A Real-World Case Report of Durable Dual Response · Oncology Research · 2026 · Same journal
• Multidimensional Regulatory Network of YAP1 Driving Malignant Progression in Esophageal Cancer: Molecular Mechanisms and Targeted Therapy: A Review · Oncology Research · 2026 · Same journal
• S100A14 Facilitates Pancreatic Cancer Progression via S100A16-Mediated p53 Suppression · Oncology Research · 2026 · Same journal
• Elucidating the Potential Targets and Mechanisms of Bisphenol A-Induced Prostate Cancer Based on Network Toxicology and Molecular Docking Analyses · Oncology Research · 2026 · Same journal
• The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) Database · Oncology Research · 2026 · Same journal
• Identify MTDH as a Key Gene of Radio-Resistance in Colorectal Cancer Based on Multi-Omics and Experimental Validation · Oncology Research · 2026 · Same journal
• Metastatic Triple Negative Breast Cancer: Navigating a Rapidly Evolving Therapeutic Landscape · Oncology Research · 2026 · Same journal
• PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway · Oncology Research · 2026 · Same journal
• Efficacy and Mechanisms of CDK4/6 Inhibitors in Breast Cancer: Advancing Targeted Therapeutic Strategies · Oncology Research · 2026 · Same journal